We are live on
!
Find out more
Roivant Sciences
ROIV
ROIV
439 hedge funds and large institutions have $14.7B invested in Roivant Sciences in 2026 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 172 increasing their positions, 121 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
109% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 45
42% more repeat investments, than reductions
Existing positions increased: 172 | Existing positions reduced: 121
33% more capital invested
Capital invested by funds: $11B → $14.7B (+$3.63B)
31% more call options, than puts
Call options by funds: $42M | Put options by funds: $32M
11% more funds holding
Funds holding: 396 → 439 (+43)
0.92% more ownership
Funds ownership: 73.16% → 74.08% (+0.92%)
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
Holders
439
Holders Change
+43
Holders Change %
+10.86%
% of All Funds
5.4%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
94
Increased
172
Reduced
121
Closed
45
Calls
$42M
Puts
$32M
Net Calls
+$9.98M
Net Calls Change
-$105M
Top Buyers
Top Sellers
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$353M |
| 2 |
Morgan Stanley
New York
|
-$168M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$103M |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$90.1M |
| 5 |
O
OrbiMed
New York
|
-$47.5M |
